Related Experiment Video
Updated: Jan 27, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
Weiyi Li1, Jing Cao2, Jian Liu1
11Eye Hospital, China Academy of Chinese Medical Sciences, No 33 Lugu Road, Shijingshan district, Beijing, 100040 China.
Background:
Cyclin-dependent kinase-like 1 (CDKL1) is a member of the cell division control protein 2-related serine-threonine protein kinase family. It is known to occur in various malignant tumors, but its role in neuroblastoma (NB) remains unclear.
Methods:
We constructed a CDKL1-silenced NB cell strain (SH-SY5Y) and used real-time PCR and western blotting to confirm the silencing. Functional analyses were performed using the MTT, colony-formation, FACS, wound-healing and transwell invasion assays.
Results:
The expression of CDKL1 was significantly upregulated in NB tissue as compared to the adjacent normal tissue. CDKL1 knockdown significantly suppressed cell viability and colony formation ability. It also induced cell cycle G0/G1 phase arrest and apoptosis, and suppressed the migration and invasion ability of SH-SY5Y cells. CDKL1 knockdown decreased the CDK4, cyclin D1 and vimentin expression levels, and increased the caspase-3, PARP and E-cadherin expression levels in SH-SY5Y cells.
Conclusions:
Our findings suggest that CDKL1 plays an important role in NB cell proliferation, migration and invasion. It might serve as a potential target for NB therapy.
Insights
Cyclin-dependent kinase-like 1 (CDKL1) is upregulated in neuroblastoma (NB). Silencing CDKL1 inhibits NB cell proliferation, migration, and invasion, suggesting CDKL1 as a potential therapeutic target for NB.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Cyclin-dependent kinase-like 1 (CDKL1) is a serine-threonine protein kinase.
- CDKL1 is implicated in various malignant tumors.
- The specific role of CDKL1 in neuroblastoma (NB) is not well understood.
Purpose of the Study:
- To investigate the role of CDKL1 in neuroblastoma (NB).
- To determine if CDKL1 could be a potential therapeutic target for NB.
Main Methods:
- Constructed a CDKL1-silenced neuroblastoma (NB) cell line (SH-SY5Y).
- Utilized real-time PCR and western blotting to confirm CDKL1 silencing.
- Performed functional assays including MTT, colony formation, FACS, wound healing, and transwell invasion.
Main Results:
- CDKL1 expression was significantly higher in NB tissues compared to normal tissues.
- CDKL1 knockdown reduced NB cell viability, colony formation, migration, and invasion.
- CDKL1 silencing induced G0/G1 cell cycle arrest and apoptosis, altering key protein expressions.
Conclusions:
- CDKL1 plays a significant role in neuroblastoma (NB) cell proliferation, migration, and invasion.
- CDKL1 may represent a promising therapeutic target for neuroblastoma treatment.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Cancer Cell Migration through Invadopodia

